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Abstract
Purpose of review—The population of chronically critically ill patients is growing as advances 
in intensive care management improve survival from the acute phase of critical illness. These 
patients are characterized by complex medical needs and heavy resource utilization. This article 
reviews evidence supporting a comprehensive approach to the prevention and management of 
chronic critical illness (CCI).
Recent findings—The most efficient approach to weaning patients with CCI at long-term acute 
care hospitals is daily unassisted breathing trials through a tracheostomy collar. However, a 
substantial number of patients transferred to long-term acute care hospitals pass their spontaneous 
weaning trials. Transfer to long-term acute care hospitals is associated with higher acute care costs 
and payments, but lower costs through the entire episode of illness. Universal decontamination is 
more effective than targeted decontamination or screening and isolation for preventing nosocomial 
bloodstream infections.
Summary—Combating CCI begins with prevention in the acute phase of illness. Management 
strategies include a spectrum of ventilatory, nutritional, and rehabilitation support. Further patient-
centered outcome-based research in this specific population is needed to continue to help guide 
optimal care.
Keywords
chronic critical illness; intensive care; multiorgan failure; prognosis; prolonged mechanical 
ventilation
INTRODUCTION
Chronic critical illness (CCI) is defining an increasing number of patients who are receiving 
treatment in the ICU. CCI is a disease state ultimately resulting from our advanced therapies 
for acute critical illness, leaving some patients with persistent multisystem organ 
dysfunction [1]. For most patients, this may not be a preventable state, but reflects advances 
in acute resuscitation and support in critical illness, where short-term mortality continues to 
decrease and high morbidity states are increasingly prevalent. For other patients, iatrogenic 
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complications and failure to prevent them can contribute to CCI. This article will review 
important strategies to decrease the incidence of CCI and reduce the burden of CCI for 
patients who are affected (Table 1).
WHAT IS CHRONIC CRITICAL ILLNESS?
Patients with CCI are a population who have survived acute critical illness or injury, but 
have persistent organ dysfunction leading to prolonged intensive care needs. They are a 
heterogeneous group of patients for which a universal definition has not yet been agreed 
upon. Many definitions include the need for prolonged mechanical ventilation (PMV). This 
has many advantages as PMV is a common requirement for the CCI patient, is easy to track 
in cohorts, and is of interest to hospital administration and payers as these are patients with 
substantial hospital costs [2,3]. The actual period that defines PMV is debatable. A 
consensus conference determined that at least 21 days of mechanical ventilation qualifies as 
PMV, whereas a current Medicare definition uses 96 h [4–6]. One group uses the term 
prolonged acute mechanical ventilation (PAMV) to represent patients who require at least 96 
h of ventilation [7]. But CCI is a syndrome that, in addition to PMV, usually includes 
profound weakness, malnutrition, anasarca, prolonged brain dysfunction, and extreme 
symptom burden. Not all patients ventilated for 96 h have yet developed this phenotype. 
Placement of a tracheostomy for PMV may be an appropriate inclusion criterion for CCI as 
tracheostomy placement indicates the care team feels the patient is not going to die or be 
liberated from mechanical ventilation in the near future [1]. A useful administrative 
definition was validated that combines tracheostomy placement for PMV and ICU length of 
stay of at least 21 days [8]. For the clinician, a precise definition is less important than 
recognition of the physical syndrome with adjustment of practices to meet the unique needs 
of the CCI patient.
KEY POINTS
• CCI is a difficult-to-define yet increasing syndrome in critical care, and 
physicians must be prepared to manage this complex patient 
population.
• Prevention strategies for CCI are anchored in systematic evidence-
based practices in the acute setting for ventilator management, 
limitation of sedation, mobility, and infection prevention.
• A multifaceted, multidisciplinary approach encompassing ventilator, 
nutritional, and rehabilitation support is required to care for chronically 
critically ill patients with a focus on patient-centered care.
• Future studies should focus on comparing specific strategies and 
protocols tailored to the unique physiology of CCI.
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Of mechanically ventilated patients in the ICUs, 5–10% develop CCI depending on the 
definition [2]. This total number of CCI patients is projected to more than double in the next 
decade, resulting in up to 605 898 cases in 2020 [9]. Hospital operating costs for CCI 
patients amount to over $12.6 billion annually, with substantial additional costs associated 
with care following hospital discharge [3,10]. Another important but difficult to quantify 
cost of CCI is caregiver/family cost. Indirect costs such as transportation, hotels, and food 
along with lost days of work should not be overlooked. One-year survival for CCI is 
between 40 and 50% based upon inclusive cohort studies [11,12▪▪,13]. Because of persistent 
physical limitations and high care needs, patients who survive their acute hospitalization 
spend much of their time in other institutions including long-term acute care (LTAC) 
hospitals or other designated weaning facilities, inpatient rehabilitation facilities, or skilled 
nursing facilities (SNFs). Patients experience a median of four transfers of care, and they 
spend over 70% of their days alive during the year in institutionalized care. Only 10% of 
CCI patients are alive and functionally independent at home after 1 year [14].
PREVENTION AND MANAGEMENT OF CHRONIC CRITICAL ILLNESS
A comprehensive, multidisciplinary approach is required in the prevention and management 
of CCI.
Mechanical ventilation
The acute respiratory distress syndrome (ARDS) and its associated causes are the most 
common conditions associated with CCI. Evidence-based management strategies including 
protective lung ventilation [15] and conservative fluid management [16] are associated with 
not only improved survival but also fewer ventilator days and ICU days for survivors. 
Strategies that reduce the incidence of ARDS, such as sepsis bundles and restrictions on 
transfusions, can also reduce ICU stays [17]. Combining daily awakening trials with daily 
spontaneous breathing trials (SBTs) is another management principle that both improves 
survival and reduces ICU stays [18].
Liberating the CCI patient from mechanical ventilation is a special challenge, but the 
approach is not very different from managing the acutely ill patient. The focus should be on 
reversing underlying causes of hypoxemia and ventilator failure while daily SBTs are 
attempted. A recent randomized controlled trial published by Jubran et al. [19▪▪] compared a 
pressure support-based weaning protocol with daily unassisted breathing trials through 
tracheostomy collars in CCI patients at an LTAC hospital. Initially, patients were screened 
with a SBT. Patients who failed the SBT within 120 h were randomized to pressure support 
ventilation with systematic reductions as tolerated versus increasing tracheostomy collar 
time during the day with full ventilator support at night. Thirty-two percent of patients 
passed the SBT, suggesting that adequate attempts to wean a substantial number of patients 
at the referring acute care ICUs were lacking. Eligible patients randomized to the 
tracheostomy collar group weaned in 15 days compared with 19 days in the pressure support 
group (P = 0.004). Mortality did not differ between the groups, with enrolled mortality 46% 
at 6 months and 55% at 1 year [19▪▪]. Most of the difference was accounted for by the 
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subgroup who failed their SBT between 12 and 120 h. The optimal approach for weaning 
patients who fail their SBT in less than 12 h is not made clear by this study, but, given their 
lower physiologic reserve, a more aggressive search for reversible causes of failure is 
indicated.
ICU-acquired weakness
ICU-acquired weakness (ICUAW) is a well-recognized complication of critical illness that is 
thought to stem from both muscle and nerve abnormalities –critical illness polyneuropathy 
(CIP) and critical illness myopathy (CIM) [20,21]. While its role in long-term functional 
disability has not been adequately defined, it clearly contributes to disability in the CCI 
patient. In one study of patients requiring at least 28 days of ventilation, neurophysiologic 
evidence of chronic partial denervation of muscle consistent with pervious CIP can be found 
up to 5 years after ICU discharge in more than 90% of patients [22]. Several risk factors that 
are common in CCI contribute to ICUAW, including prolonged immobility, hyperglycemia, 
systemic inflammation, and multiple organ dysfunction [20,23]. Mitochondrial dysfunction 
contributing to diaphragmatic weakness and functional limitation has been proposed as one 
pathophysiologic explanation for ICUAW [24]. The role of systemic corticosteroids in 
ICUAW remains unclear, but exposure should be minimized until future studies provide 
clarification [21]. Tight glycemic control as a means to combat ICUAW is controversial, but 
insulin therapy to main glucose levels between 150 and 180 mg/dl is recommended in both 
the acute and chronic phases of critical illness [21,25▪]. Another proposed intervention to 
reduce ICUAW is early and continued mobility in the ICU. Recent literature has shown that 
early mobility is safe, and decreases ICU and possibly hospital length of stay without 
increasing costs [26,27▪]. Coordination between nurses and physical and respiratory 
therapists is the key to initiate a successful mobility program for critically ill patients. The 
benefit of continued mobility for CCI patients is yet to be studied, though intuitively it has 
been felt to be beneficial. This has long been a cornerstone of the multidisciplinary 
rehabilitation approach to care that characterizes the long term acute care hospital (LTACH) 
model.
Nutrition and metabolic support
Intensive metabolic support (IMS) is a term coined to describe metabolic control with 
insulin therapy, early and consistent nutrition support, and nutritional pharmacology in 
critically ill patients [28]. Although strong evidence is lacking, it is thought that focusing on 
metabolic support may help reverse the pathophysiology associated with CCI. Malnutrition 
is reported in up to 43% of critically ill patients, which is associated with increased 
morbidity and mortality, infection rates, length of ICU stay, poor wound healing, and muscle 
weakness [29]. Therefore, a thorough nutritional assessment should be performed by a 
qualified provider to form the optimal nutrition plan including caloric, protein, electrolyte, 
and vitamin and mineral support.
Data support the use of enteral nutrition in critically ill patients with a functioning 
gastrointestinal tract. A recent study revealed that nasojejunal versus nasogastric feeds in 
mechanically ventilated patients did not improve nutritional targets [30▪]. The timing of 
enteral and parenteral nutrition therapy has been a topic of recent clinical trials. The ARDS 
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Clinical Trials Network published the EDEN trial, finding no significant differences in 
mortality or ventilator-free days between enteric full and trophic feeds for up to 6 days in 
patients with ARDS [31▪▪]. In a follow-up study, they reported that ARDS patients have 
substantial physical, psychological, and cognitive impairments, reduced quality of life, 
substantial need for institutional care and impaired return to work, but mean physical 
function and survival at 12 months were not affected by initial trophic versus full feed [32▪].
A recent randomized trial has shown that adding parenteral to enteral to accomplish 100% of 
nutritional goals in mechanically ventilated patients from day 3 to 8 in the ICU showed a 
decrease in later (days 9–28) nosocomial infections (27 versus 38%, respectively); however, 
this was not statistically significant. There was no change in time on mechanical ventilation, 
ICU and hospital length of stay, or ICU and hospital mortality [33▪]. These studies address 
early nutrition in the acute phase of critical illness. Data for optimum calorie delivery in CCI 
patients are lacking, largely because few investigators would consider that underfeeding 
patients for weeks would be beneficial. However, overfeeding may be more common than 
underfeeding and is similarly undesirable with increased infectious complications, liver 
dysfunction, and increased mortality [34]. Therefore clinical trials of effective nutrition 
assessment and delivery strategies are needed for the CCI population.
Another metabolic complication of CCI is hyper-resorption of the skeleton marked by 
elevated osteoclast activity. A study by Via et al. [35] showed that a single intravenous dose 
of a bisphosphonate had a measurable transient effect in osteoclast activity in patients with 
CCI. Studies of longer-term therapy and outcomes are worth exploring further.
Cognitive impairment and mental health
Brain dysfunction is a frequent complication of critical illness, resulting from a myriad of 
insults such as toxic or metabolic derangements, ischemic or traumatic brain injury, or as 
side effects of medications, especially sedating agents commonly used in the ICU [36]. It 
can manifest as coma or delirium, and, when measured in CCI patients after transfer to 
facilities specializing in CCI, incidence has been shown to be 17–70% initially, whereas 
long-term occurrence is 40–74% [37–41]. It is known that 20–80% of ICU survivors at 1 
year have long-term cognitive impairment, and there may be a relationship between acute 
delirium and long-term impairment [37]. Most important in management of delirium is to 
evaluate for a cause that is modifiable in any acute mental changes including infection, 
hypotension, electrolyte imbalance, hypoxia, and sedating medications [36]. Depression and 
post-traumatic stress disorder are very common in CCI patients [41,42]. Denehy and Elliott 
[43] point out the challenges of screening and treating mental health issues such as 
depression, anxiety, and sleep disturbances in the critically ill. This is obviously an 
important issue to address in CCI patients and will need the support of the entire care team 
in management.
Nosocomial infections
Chronic critical illness patients have a host of indwelling devices (urinary catheters, 
endotracheal or tracheostomy tubes, nasogastric tubes, intravenous catheters) often for a 
prolonged time that put them at a daily risk for nosocomial infections. Additionally, they 
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reside in environments in which frequent multidrug-resistant organisms (MDROs) exist. One 
study of LTACH admissions found 69% of patients were colonized with at least one MDRO 
[44]. Diminished immunological and physiologic reserve following severe sepsis, referred to 
as ‘immune exhaustion’, is another proposed mechanism that puts CCI patients at risk [45]. 
Additionally, many CCI patients have pre-existing comorbid conditions such as hepatic 
failure, renal failure, or malignancy that predispose them to decreased immune function 
[46].
It is important to continue prevention strategies for nosocomial infections throughout the 
CCI patient’s hospitalization. The infection with the highest associated mortality rate is 
catheter-associated bloodstream infections (CABSIs). Systematic prevention strategies are 
well proven and should be in place in both the acute ICU and LTAC settings [47]. Similar 
systematic prevention strategies for ventilator-associated pneumonia are also important to 
reduce morbidity and length of stay [48]. Catheter-associated urinary tract infections 
(CAUTIs) are common in CCI as the urinary catheter rate in CCI patients is high. Staff 
education in basic infection control and minimizing use of urinary catheters have been 
shown to reduce the rate of CAUTIs in hospitalized patients [46]. In a recent review, 
Cabrera-Cancio [46] suggests a combination of judicious use of antibiotics (antimicrobial 
stewardship) to help decrease rates of MDRO and Clostridium difficile, surveillance cultures 
to guide isolation practices, family/patient education, and strict housekeeping protocols to 
decrease incidence of nosocomial infections in the CCI. A recent cluster randomized trial of 
ICUs revealed that universal decontamination using 5 days of twice-daily intranasal 
mupiricin and daily bathing with chlorhexidine-impregnated cloths was more effective than 
targeted decontamination or screening and isolation of colonized patients in reducing rates 
of methicillin-resistant Staphylococcus aureus clinical isolates and bloodstream infections of 
any type [49▪▪].
PATIENT-CENTERED CARE
Eliciting patient values and preferences, often through early structured conversations with 
proxy decision makers, remains important to provide a level of care that meets the wishes of 
patients with CCI. Most patients do not have identified proxy decision makers or signed 
advance directives [50], which necessitates early and frequent conversations with families 
and caregivers regarding patient wishes, thresholds for continuation or discontinuation of 
life-prolonging therapies, open and honest communication about nature and location of 
eventual discharge (if likely), and preparedness planning for both performing interventions 
(e.g. hemodialysis and enteral feeding) and potentially stopping them. This occasionally 
requires the services of consultative palliative care teams for complex clinical and 
psychosocial situations [51]. CCI patients are a heterogeneous group; thus, being able to 
distinguish between high and low-risk patients would be helpful both for the care team and 
family/ decision makers. The ProVent score was developed as a mortality prediction model 
using four clinical variables (age, platelet count, requirement for vasopressors, and 
hemodialysis) on day 21 of mechanical ventilation to identify patients at high and low risk 
of mortality [12▪▪], and can be used to guide families and the care team in their discussions. 
Written information regarding CCI is available for families [52], as are tools to evaluate the 
satisfaction of communication perceived by families [53]. An innovative decision aid to 
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assist with communication of prognosis and goals of care is currently being studied in a 
multicenter randomized trial [54▪].
VENUES OF CARE
Management of CCI is complex and requires a fully integrated interdisciplinary team (Fig. 
1), but this rehabilitation approach can be implemented in sites other than an acute ICU for 
stable patients. Deciding if, where, and when to transfer care of a CCI patient is a regular 
challenge for the critical care team, assuming transfer options are available. LTAC hospitals 
are an option in some regions in the US [55,56▪]. Kahn et al. describe outcomes of Medicare 
beneficiaries with CCI who are discharged to LTACs. Out of 234 799 CCI patients, 48 416 
(20.6%) were discharged to an LTACH. In an adjusted analysis, no association was found 
between LTACs and 1-year survival. The 180-day hospitalization-related costs were lower 
for patients who spent time in an LTAC, but actual Medicare payments were higher. A 
similar finding was noted in a large centers for Medicare and Medicaid services (CMS)-
funded study [10]. The authors conclude that LTAC transfer shows a potential for cost-
saving if payment models are re-evaluated by policy makers [57▪▪]. There is significant 
regional variation in LTAC availability in the US, and there is also variability in utilization of 
LTACs in regions where they are available [58▪]. Free standing weaning facilities are less 
common outside the US, although this model is being explored in a number of European 
countries with projections of cost-savings [59–61]. Other options include keeping CCI 
patients in the acute care ICU with specialized consultation [62], or transferring to a step-
down unit or a hospital-based respiratory care unit (RCU). The best option will vary by 
patient and family circumstances and local resources.
CONCLUSION AND FUTURE DIRECTIONS
Combating CCI begins with prevention efforts, including systematic application of evidence-
based practices in acute critical care settings, such as early goal-directed therapy, lung 
protective ventilation, daily awakening and SBTs, early mobility, and prevention of 
nosocomial infections. Management of CCI requires ventilator, nutrition, and rehabilitation 
strategies tailored to the unique physiology of CCI. Research is needed to better define 
physiologic differences so that CCI-specific clinical protocols can be developed and 
compared [63]. Further innovations to improve shared decision-making for CCI patients and 
their families are also needed.
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Table 1
Management of chronic critical illness
Type of support Management principles Barriers/challenges Potential future research
Mechanical ventilation Prevents CCI with lung protective 
ventilation, conservative fluid 
management, daily awakening, and 
SBTs
Patients cared for in a variety of 
settings (ICUs, LTACHs) with 
various weaning strategies
Identifying risk factors for 
requirement of PMV
Weaning with SBTs and rests with 
full ventilator support
Functional recovery Prevent hyperglycemia with insulin 
infusions if necessary
Early mobility must be accepted 
and promoted by all facets of 
the critical care team to be 
feasible
Effect of aggressive mobility on long-
term functional outcomes
Early mobility is safe and effective in 
critical illness
Nutritional and metabolic 
support
Both underfeeding and overfeeding 
have been linked with detrimental 
results in CCI
Favored route, EN, often 
difficult to provide 100% 
nutrition needs with unclear 
long term effects in CCI
Long-term effects of different feeding 
strategies
EN over PN currently favored Difficult to calculate nutrition 
and metabolic needs in the CCI 
population
Identify other nutritional supplements 
for improved functional outcomes
Cognitive and mental 
health
Minimize sedating medications while 
preventing/treating delirium and pain
Distinguishing agitation, 
delirium and pain is difficult 
and there are no proven 
therapies for delirium
Identifying long-term cognitive 
effects of CCI
Develop targeted therapies directed at 
brain dysfunction in CCI
Nosocomial infection Adhering to prevention strategies with 
VAP bundle sets and CVC insertion 
checklists
CCI patients are medically 
complex, requiring many 
interventions putting them at 
risk for infection
Establishing uniform isolation and 
decontamination practices for CCI
Remove/reduce use of indwelling 
devices
Identifying strategies to decrease 
antibiotic use in CCI patients
Consider nasal and skin 
decontamination in addition to 
isolation
Determine if rates of infection change 
between type of care facility (LTACH 
versus ICU)
Patient-centered care Solicitation of patient values and 
preferences, starting at admission
Caregivers and decision makers 
are often intermittently 
available, necessitating need for 
scheduled, regular conferences 
for information updates and 
decision making
Understanding how decision makers’ 
values and preferences change 
throughout the ICU stay
Frequent communication with 
decision makers, using multiple 
modalities for education
Investigate best practices for 
providing information and giving 
recommendations for care that are 
feasible and acceptable to caregivers
Incorporation of consultative 
palliative care (and other 
complementary) services when 
complex needs arise
CCI, chronic critical illness; CVC, central venous catheter; EN, enteral nutrition; LTACH, long term acute care hospital; PMV, prolonged 
mechanical ventilation; PN, parenteral nutrition; VAP, ventilator associated pneumonia.
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